Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Dysgerminoma of the ovary: good prognosis even in advanced stagesM S Zaghloul, T Y KhattabInternational Journal of Radiation Oncology, Biology, Physics|February 1, 1991
Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systemsR F Kallman, D Rapacchietta, M S ZaghloulJournal of Surgical Oncology|May 1, 1994
Wilms' tumor: long-term results from a single institutionM S Zaghloul, M H Hussein, M el KoutbeyInternational Journal of Radiation Oncology, Biology, Physics|June 15, 1993
Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum, and tumorM S Zaghloul, M J Dorie, R F KallmanInternational Journal of Radiation Oncology, Biology, Physics|July 1, 1994
Interleukin 1 increases thymidine labeling index of normal tissues of mice but not the tumorM S Zaghloul, M J Dorie, R F KallmanClinical Oncology (Royal College of Radiologists (Great Britain))|May 11, 2021
Adjuvant and Neoadjuvant Radiation Therapy for Locally Advanced Bladder CancerB C Baumann, M S Zaghloul, P Sargos, et al.Human & Experimental Toxicology|October 2, 2015
Effect of agmatine on experimental vascular endothelial dysfunctionM A Nader, N M Gamiel, H El-Kashef, et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|May 1, 1989
Interleukin 1 protects against the lethal effects of irradiation of mice but has no effect on tumors in the same animalsM J Dorie, A C Allison, M S Zaghloul, et al.European Journal of Cancer (Oxford, England : 1990)|July 26, 2000
A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinomaH M Khaled, M R Hamza, O Mansour, et al.Pageof 3